Statistics for Proteomic assessment of SKBR3/HER2+ breast cancer cellular response to Lapatinib and investigational Ipatasertib kinase inhibitors

Total visits

views
Proteomic assessment of SKBR3/HER2+ breast cancer cellular response to Lapatinib and investigational Ipatasertib kinase inhibitors 4

Total visits per month

views
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 4

File Visits

views
Proteomic assessment of SKBR3HER2+ breast cancer cellular response to Lapatinib and investigational Ipatasertib kinase inhib.pdf 2